Istiratumab companion diagnostic (Merrimack Pharmaceuticals)

N/A

Report date: 2025/03/13 11:13:56

Base Information

Drug NameIstiratumab companion diagnostic (Merrimack Pharmaceuticals)
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerrimack Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerrimack Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A